Skip to main content

Find Clinical Trials

Home
Conditions
Disease Progression

Clinical trial condition

Disease Progression

Explore clinical trials studying Disease Progression. Study availability and eligibility vary by location and protocol.

126 public trials 38 recruiting studies

Refine in advanced search Browse all conditions

Disease Progression trial results

Recruiting

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

NCT06647680

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +14 more
Locations: The affiliated hospital of Qingdao university Qingdao, Shandong, China

View Trial Details

Recruiting

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

NCT06130995

Conditions: Androgen Deprivation Therapy, Disease Attributes, Disease Progression, +7 more
Locations: Stephenson Cancer Center at OU Health, University of Oklahoma Health Sciences Center (SCC-OUHSC) Oklahoma City, Oklahoma, United States

View Trial Details

Recruiting

Predicting ICU Transfers and Other Unforeseen Events (PICTURE)-Pediatric

NCT07304050

Conditions: Clinical Deterioration, Disease Attributes, Disease Progression, +2 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Recruiting

Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

NCT07430579

Conditions: Disease Attributes, Disease Progression, Immune-Related Adverse Events, +6 more
Locations: The Second Qilu Hospital of Shandong University Jinan, China

View Trial Details

Recruiting

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

NCT04055220

Conditions: Angiosarcoma, Behavior, Bone Diseases, +31 more
Locations: Hôpital Jean Minjoz Besançon, France

Institut Bergonié Bordeaux, France

Centre Oscar Lambret Lille, France

Centre Léon Bérard Lyon, France

View all 16 locations

View Trial Details

Recruiting

Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

NCT07353723

Conditions: Disease Attributes, Disease Progression, Head & Neck Cancer, +6 more
Locations: Tangdu Hospital, Air Force Medical University, Xi'an 710038, Shaanxi Province, China Shanxi, Province, China

View Trial Details

Recruiting

T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR

NCT07353840

Conditions: Disease Attributes, Disease Progression, Hemic and Lymphatic Diseases, +14 more
Locations: Shanghai General Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma

NCT07328854

Conditions: Carcinoma, Disease Attributes, Disease Progression, +16 more
Locations: Anhui Provincial Cancer Hospital Hefei, Anhui, China

Fujian Cancer Hospital Fuzhou, Fujian, China

Sun Yat-sen University cancer center Guangzhou, Guangdong, China

the Affiliated Cancer Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

View all 15 locations

View Trial Details

Recruiting

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

NCT07328841

Conditions: Carcinoma, Disease Attributes, Disease Progression, +17 more
Locations: The Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

Cancer Center of Guangzhou Medical University Guangzhou, Guangdong, China

Sun Yat-sen University cancer center Guangzhou, Guangdong, China

The Second Affiliated Hospital of Sun Yat-sen University (SYSU) Guangzhou, Guangdong, China

View Trial Details

Recruiting

Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer

NCT06364371

Conditions: Disease Attributes, Disease Progression, Pathologic Complete Response, +3 more
Locations: The Sixth Affiliated Hospital, Sun Yatsen University Guangzhou, Guangdong, China

View Trial Details